CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use
Related Experiment Videos
J M Taylor1, J L Fahey, R Detels
1Division of Biostatistics, School of Public Health, University of California, Los Angeles 90024.
Insights
This study followed 813 HIV-positive men for 3 years, monitoring CD4 cell counts to predict disease progression. CD4 percent showed slightly better prognostic value and less variability than CD4 absolute number for predicting AIDS.
Area of Science:
- Immunology
- Virology
- Clinical Medicine
Background:
- Untreated HIV infection leads to immune deterioration, primarily monitored by CD4 T-lymphocyte counts.
- Accurate prognostication of HIV disease progression is crucial for patient management and clinical trial stratification.
Purpose of the Study:
- To evaluate the prognostic significance of different CD4 count metrics in predicting AIDS progression in untreated HIV-seropositive men.
- To compare the utility of absolute CD4 count, CD4 percentage, and CD4:CD8 ratio for monitoring HIV disease.
Main Methods:
- A 3-year longitudinal study involving 813 untreated HIV-seropositive men.
- Baseline CD4 levels were used for disease severity stratification.
- CD4 levels and progression to Acquired Immunodeficiency Syndrome (AIDS) were evaluated over time.
Main Results:
- Absolute CD4 count, CD4 percentage, and CD4:CD8 ratio were all strongly correlated and showed similar abilities to predict AIDS development.
- CD4 percentage demonstrated slightly greater prognostic significance and less variability in repeated measurements compared to absolute CD4 count.
- All three markers are useful for monitoring individuals with HIV infection.
Conclusions:
- CD4 percentage may be preferable to absolute CD4 count for stratifying patients for antiviral/immunotherapy and for monitoring in clinical trials due to its prognostic advantage and lower variability.
- These findings provide valuable data for advising HIV-seropositive patients on their prognosis based on CD4 cell levels.
- CD4 metrics serve as reliable indicators for tracking immune status and predicting clinical outcomes in HIV infection.
Abstract:
Data from a 3 year longitudinal study of CD4 levels in 813 untreated HIV-seropositive men are presented. Baseline CD4 levels were used to stratify the men for the severity of HIV disease at the outset of the study, and each man's CD4 levels and progression to AIDS were evaluated. These data can be used to advise patients who are HIV seropositive on the likelihood that they will deteriorate immunologically or progress to AIDS based on their own CD4 cell level obtained from laboratory evaluation. Graphs are presented here for 1, 2, and 3 years of follow-up. As expected, each individual's absolute CD4 lymphocyte number, CD4 lymphocyte percent, and CD4:CD8 ratio were strongly correlated, and were similar in their ability to predict the development of AIDS. In this sense, all three are useful markers for monitoring individuals with HIV infection, and for many clinical situations from a practical point of view there is little to choose between the markers. However, the CD4 percent has slightly greater prognostic significance and shows slightly less variability on repeated measurements. Because of this, the CD4 percent may be preferable to the CD4 absolute number for use in stratifying individuals who are candidates for antiviral or immunotherapy for HIV infection, and for monitoring patients in clinical trials.